Possible Therapy by Phone for Caregivers
TACTICs
Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults With Alzheimer's Disease and Related Dementias. A Single Arm Pilot
1 other identifier
interventional
20
1 country
1
Brief Summary
Caregivers of adults with dementia report higher stress, including anxiety and depressive symptoms, burden, and existential suffering, than caregivers of people with other chronic diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable anxiety
Started Jun 2019
Shorter than P25 for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 9, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 9, 2019
CompletedFirst Submitted
Initial submission to the registry
November 3, 2020
CompletedFirst Posted
Study publicly available on registry
November 18, 2020
CompletedMarch 29, 2023
March 1, 2023
6 months
November 3, 2020
March 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anxiety symptoms measured by the Generalized Anxiety Disorder Scale (GAD-7)
Anxiety will be measured using the GAD-7 which contains 7 items with total scores ranging from 0 to 21. Scores of 5, 10 and 15 are cut off scores for mild, moderate and severe anxiety respectively. An add-on item assessing the patient's global impression of symptom related impairment helps researchers understand the extent to which anxiety interferes in daily life. The GAD-7 has factorial validity for the diagnosis of general anxiety disorder and is sensitive to change
through study completion, an average of 6 months
Secondary Outcomes (7)
Depressive symptoms measured by the Patient Health Questionnarie-9 (PHQ-9)
through study completion, an average of 6 months
Caregiver burden measured by the Zarit Burden Interview (ZBI)
through study completion, an average of 6 months
Physical, emotional and existential suffering to caregivers measured by the Experience of Suffering Scale (ESS)
through study completion, an average of 6 months
Different strategies that caregivers use to cope measured with the Brief COPE
through study completion, an average of 6 months
Caregivers psychological flexibility measured by the Acceptance and Action Questionnaire-II (AAQ-II)
through study completion, an average of 6 months
- +2 more secondary outcomes
Other Outcomes (2)
The feasibility of the TACTICs Intervention will be measured by accrual rate, attendance of sessions, and the retention in the study
baseline and through study completion, an average of 6 months.
Caregivers acceptability of the TACTICs intervention
through study completion, an average of 6 months
Study Arms (1)
Experimental TACTICs
OTHERTelephone Acceptance and Commitment Therapy Intervention for Caregivers of adults with dementia (TACICS. Participants will receive a manualized acceptance and commitment therapy intervention delivered via phone in 6 weekly 1 hour sessions by a trained interventionalist
Interventions
6 weeks of 1 hour sessions with a masters prepared research specialist to deliver validated tools
Eligibility Criteria
You may qualify if:
- years or older
- Able to communicate in English
- Able to provide informed consent
- Listed as primary caregiver in the chart of a patient with Alzheimer's disease or related dementia (DARD)
- Intends to continue caregiving form ADRD patient for at least 12 months or greater
- Clinically elevated anxiety score (score of 10 or higher on GAD-7)
You may not qualify if:
- Non-family member of the ADRD patient
- Has ADRD or other serious mental illness diagnosis such as bipolar or schizophrenia as determined by ICD-10 code
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- Regenstrief Institute, Inc.collaborator
Study Sites (1)
Regenstrief Institute, Inc.
Indianapolis, Indiana, 46202-4800, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shelley A. Johns, PhD
Indiana University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
November 3, 2020
First Posted
November 18, 2020
Study Start
June 14, 2019
Primary Completion
December 9, 2019
Study Completion
December 9, 2019
Last Updated
March 29, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Spring, 2021
- Access Criteria
- manuscripts
In future manuscripts, the authors will list contact information and state that IPD is available upon request